J. Guilhot | Charles Explorer

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

2018 | Publikace bez příslušnosti k fakultě